There is no published clinical data on the combination of AOD 9604 and semaglutide
We offer FDA-approved treatments, off-label options, and customized compounded formulations tailored to meet individual patient needs
In the Phase 1b trial of higher doses (9 mg and 10 mg), 95% of participants experienced at least one adverse event, but only one participant discontinued treatment due to side effects
As research into the medications has continued, they have been discovered to have uses in treating other health conditions and preventing health issues, including heart disease and cancer
Can these peptides be combined with phentermine or other weight loss medications
These experimental compounds are ryanodine receptor-1-calstabin complex stabilizers, which are involved in skeletal muscle function